Urinary enterolignans and enterolignan-predicting microbial species are favourably associated with liver fat and other obesity markers.
Yufeng MoYamin LiShaoxian LiangWuqi WangHonghua ZhangJiajia ZhaoMengting XuXiaoyu ZhangHongjuan CaoShaoyu XieYaning LvYaqin WuZhuang ZhangWanshui YangPublished in: Food & function (2024)
Aims : Plant-derived lignans may protect against obesity, while their bioactivity needs gut microbial conversion to enterolignans. We used repeated measures to identify enterolignan-predicting microbial species and investigate whether enterolignans and enterolignan-predicting microbial species are associated with obesity. Methods : Urinary enterolignans, fecal microbiota, body weight, height, and circumferences of the waist (WC) and hips (HC) were repeatedly measured at the baseline and after 1 year in 305 community-dwelling adults in Huoshan, China. Body composition and liver fat [indicated by the controlled attenuation parameter (CAP)] were measured after 1 year. Multivariate-adjusted linear models and linear mixed-effects models were used to analyze single and repeated measurements, respectively. Results : Enterolactone and enterodiol levels were both inversely associated with the waist-to-hip ratio, body fat mass (BFM), visceral fat level (VFL), and liver fat accumulation (all P < 0.05). Enterolactone levels were also associated with lower WC ( β = -0.0035 and P = 0.013) and HC ( β = -0.0028 and P = 0.044). We identified multiple bacterial genera whose relative abundance was positively associated with the levels of enterolactone (26 genera) and enterodiol (22 genera, all P false discovery rate < 0.05), and constructed the enterolactone-predicting microbial score and enterodiol-predicting microbial score to reflect the overall enterolignan-producing potential of the host gut microbiota. Both these scores were associated with lower body weight and CAP (all P < 0.05). The enterolactone-predicting microbial score was also inversely associated with the BFM ( β = -0.1128 and P = 0.027) and VFL ( β = -0.1265 and P = 0.044). Conclusion : Our findings support that modulating the host gut microbiome could be a potential strategy to prevent obesity by enhancing the production of enterolignans.
Keyphrases
- body weight
- microbial community
- insulin resistance
- body composition
- metabolic syndrome
- adipose tissue
- weight loss
- body mass index
- type diabetes
- weight gain
- high fat diet induced
- community dwelling
- fatty acid
- small molecule
- risk assessment
- skeletal muscle
- antibiotic resistance genes
- bone mineral density
- physical activity
- wastewater treatment
- single cell
- neural network